INTERLEUKIN-17 OR TNF BLOCKADE IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AFTER WITHDRAWAL OF AT LEAST ONE TNF INHIBITOR

被引：0
|
作者：
Tellenbach, Christoph [1 ]
Micheroli, Raphael [1 ]
Buerki, Kristina [1 ]
Scherer, Almut [2 ]
Nissen, Michael [3 ]
Zufferey, Pascal [4 ]
Exer, Pascale
Moeller, Burkhard [5 ]
Kyburz, Diego [6 ]
Ciurea, Adrian [1 ]
机构：
[1] Univ Hosp Zurich, Zurich, Switzerland
[2] SCQM Fdn, Zurich, Switzerland
[3] Univ Hosp Geneva, Geneva, Switzerland
[4] Univ Hosp, Lausanne, Switzerland
[5] Inselspital Bern, Bern, Switzerland
[6] Univ Hosp, Basel, Switzerland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.2427
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0237
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [31] Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort
    Adrian Ciurea
    Pascale Exer
    Ulrich Weber
    Giorgio Tamborrini
    Beate Steininger
    Rudolf O. Kissling
    Jürg Bernhard
    Almut Scherer
    Arthritis Research & Therapy, 18
  • [32] BMI IS ASSOCIATED WITH BOTH DISEASE ACTIVITY AND TNF-α INHIBITOR SERUM TROUGH LEVELS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS ON LONG-TERM TREATMENT WITH TNF-α INHIBITORS
    De Wolff, L.
    Arends, S.
    Brouwer, E.
    Bootsma, H.
    Spoorenberg, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1257 - 1258
  • [33] Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy
    Der-Yuan Chen
    Yi-Ming Chen
    Hsin-Hua Chen
    Chia-Wei Hsieh
    Chi-Chen Lin
    Joung-Liang Lan
    Arthritis Research & Therapy, 13
  • [34] Dual Blockade of TNF and IL-17A Inhibits Inflammation and Structural Damage in a Rat Model of Spondyloarthritis
    Hammoura, Ihsan
    Fiechter, Renee H.
    Bryant, Shaughn H.
    Westmoreland, Susan
    Kingsbury, Gillian
    Waegell, Wendy
    Tas, Sander W.
    Baeten, Dominique L.
    van de Sande, Marleen G. H.
    van Tok, Melissa N.
    van Duivenvoorde, Leonie M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
  • [35] HIGH NEED FOR ANTI-TNF THERAPY AFTER WITHDRAWAL STRATEGY IN EARLY PERIPHERAL SPONDYLOARTHRITIS
    Carron, P.
    Varkas, G.
    Renson, T.
    De Craemer, A. -S.
    Elewaul, D.
    Van den Bosch, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 213 - 214
  • [36] HIGH NEED FOR ANTI-TNF THERAPY AFTER WITHDRAWAL STRATEGY IN EARLY PERIPHERAL SPONDYLOARTHRITIS
    Carron, P.
    Varkas, G.
    Renson, T.
    De Craemer, A.
    Elewaut, D.
    Van den Bosch, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 700 - 700
  • [37] Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy
    Chen, Der-Yuan
    Chen, Yi-Ming
    Chen, Hsin-Hua
    Hsieh, Chia-Wei
    Lin, Chi-Chen
    Lan, Joung-Liang
    ARTHRITIS RESEARCH & THERAPY, 2011, 13 (04)
  • [38] SERUM IL-12/23 AND IL-17 LEVELS IN PATIENTS WITH SPONDYLOARTHRITIS WERE NOT INFLUENCED BY TNF-BLOCKADE
    Murakami, M.
    Nishimoto, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1646 - 1646
  • [39] High Need for Anti-TNF Therapy after Withdrawal Strategy in Early Peripheral Spondyloarthritis
    Carron, Philippe
    Varkas, Gaelle
    Renson, Thomas
    Colman, Roos
    Elewaut, Dirk
    van Den Bosch, Filip
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [40] EFFECTIVENESS OF SWITCHING BETWEEN TNF INHIBITORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: IS THE REASON TO SWITCH RELEVANT?
    Rodrigues-Manica, S.
    Sepriano, A.
    Pimentel Dos Santos, F.
    Gouveia, N.
    Barcelos, A.
    Branco, J.
    Bernardes, M.
    Ferreira, R.
    Vieira-Sousa, E.
    Barreira, S. C.
    Vinagre, F.
    Roque, R.
    Santos, H.
    Madeira, N.
    Rovisco, J.
    Daniel, A.
    Ramiro, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 731 - 731
12345